🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 69404D108 (prev. 00430H102 )
- Market Cap
- Mid Cap
- Previous Symbol
- AXDX (changed 5/9/2025)
- Previous Name
- Accelr8 Technology Corp.
Business: Accelerate Diagnostics, Inc., is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno™ system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for serious infections. The FDA-cleared system and kit fully automate sample preparation steps, enabling phenotypic antibiotic susceptibility results in about 7 hours directly from positive blood cultures.
Notes: May 8, 2025 -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (“Accelerate” or the Company”) today announced that it has voluntarily initiated a Chapter 11 restructuring proceeding in the United States Bankruptcy Court for the District of Delaware (“Bankruptcy Court”) and will seek to sell its assets through a court supervised sale process.
Company Contact
- CEO
- Jack Phillips
- CFO
- David Patience
- Headquarters
- 3950 South Country Club, Suite 470, Tucson, AZ 85714
- Phone
- 520-365-3100
- Fax
- 520-269-6580
- Investor Relations
- Laura Pierson · 520-365-3100 · investors@axdx.com